Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodosios D Filippatos

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Cardiovascular Drugs and Therapy|May 18, 2012
A review of time courses and predictors of lipid changes with fenofibric acid-statin combinationTheodosios D Filippatos
Angiology|November 8, 2021
Non-Alcoholic Fatty Pancreas Disease: A Diagnosis of Increasing ImportanceTheodosios D Filippatos
World Journal of Diabetes|May 4, 2011
Combination drug treatment in obese diabetic patientsTheodosios D Filippatos, Moses S Elisaf
World Journal of Hepatology|December 17, 2010
Combination drug treatment in patients with non-alcoholic fatty liver diseaseTheodosios D Filippatos, Moses S Elisaf
World Journal of Diabetes|October 23, 2013
Effects of glucagon-like peptide-1 receptor agonists on renal functionTheodosios D Filippatos, Moses S Elisaf
Expert Opinion on Pharmacotherapy|July 9, 2011
Fenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemiaTheodosios D Filippatos, Moses S Elisaf
World Journal of Cardiology|July 27, 2013
High density lipoprotein and cardiovascular diseasesTheodosios D Filippatos, Moses S Elisaf
Current Pharmaceutical Design|September 19, 2023
Interleukin-6 Inhibition and Lipoprotein(a): An Association Requiring More ResearchAris P Agouridis, Theodosios D Filippatos
World Journal of Cardiology|October 11, 2013
Hyponatremia in patients with heart failureTheodosios D Filippatos, Moses S Elisaf
Current Vascular Pharmacology|May 1, 2013
Recommendations for severe hypertriglyceridemia treatment, are there new strategies?Theodosios D Filippatos, Moses S Elisaf
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Cardiovascular Drugs and Therapy|May 18, 2012
A review of time courses and predictors of lipid changes with fenofibric acid-statin combinationTheodosios D Filippatos
Angiology|November 8, 2021
Non-Alcoholic Fatty Pancreas Disease: A Diagnosis of Increasing ImportanceTheodosios D Filippatos
World Journal of Diabetes|May 4, 2011
Combination drug treatment in obese diabetic patientsTheodosios D Filippatos, Moses S Elisaf
World Journal of Hepatology|December 17, 2010
Combination drug treatment in patients with non-alcoholic fatty liver diseaseTheodosios D Filippatos, Moses S Elisaf
World Journal of Diabetes|October 23, 2013
Effects of glucagon-like peptide-1 receptor agonists on renal functionTheodosios D Filippatos, Moses S Elisaf
Expert Opinion on Pharmacotherapy|July 9, 2011
Fenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemiaTheodosios D Filippatos, Moses S Elisaf
World Journal of Cardiology|July 27, 2013
High density lipoprotein and cardiovascular diseasesTheodosios D Filippatos, Moses S Elisaf
Current Pharmaceutical Design|September 19, 2023
Interleukin-6 Inhibition and Lipoprotein(a): An Association Requiring More ResearchAris P Agouridis, Theodosios D Filippatos
World Journal of Cardiology|October 11, 2013
Hyponatremia in patients with heart failureTheodosios D Filippatos, Moses S Elisaf
Current Vascular Pharmacology|May 1, 2013
Recommendations for severe hypertriglyceridemia treatment, are there new strategies?Theodosios D Filippatos, Moses S Elisaf
Pageof 10